Showcasing Scientific Innovation: Airmid Healthgroup Presents Research at EAACI 2025

by Oliver Dsa, MSc.,Senior Virologist at Airmid Healthgroup, where he leads testing and research on airborne pathogens, indoor air quality, and antiviral technologies in real-world environments.

Advancing Science: Airmid Healthgroup Research Featured at EAACI 2025

Airmid Healthgroup logo or promotional image for their participation in EAACI Congress 2025 in Glasgow, showcasing their expertise in indoor air quality and allergen testing.We are excited to announce that Airmid Healthgroup a leading Dublin-based biomedical research organisation specialising in indoor air quality and allergen testing, is set to participate in the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025. The event will be held from June 13th to 16th at the Scottish Event Campus (SEC) in Glasgow, Scotland.

EAACI 2025,  themed “Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future”, aims to highlight the critical links between environmental change and allergic diseases. As a participant, Airmid Healthgroup will have the opportunity to engage with leading experts, explore innovative approaches towards global health changes, and present their latest research findings which evaluate advanced fabric care technologies which mitigate the risk of asthma, as well as, air cleaning technologies on novel environmental allergens.

Poster Presentations at EAACI 2025 by Oliver Dsa, MSc

Oliver Dsa, Senior Virologist at Airmid Healthgroup working in a virology biosafety lab
Oliver Dsa leads virology and airborne virus testing at Airmid Healthgroup

As part of the scientific program, Oliver Dsa, MSc, Senior Virologist and Infectious Aerosols & Bioaerosol Containment Expert at Airmid Healthgroup, will present new research that demonstrates the organisation’s commitment to improving indoor environmental quality and supporting respiratory health.

1. Evaluating Advanced Fabric Care Technologies for Effective Dust Mite Eradication to Mitigate the Risk of Asthma
This study evaluates the effectiveness of high-temperature vapour cycles in eradicating dust mites from household fabrics. Findings suggest a significant advancement in allergen control, offering practical strategies to reduce exposure and mitigate the risk of asthma, particularly important in homes where vulnerable individuals reside.

2. Evaluating the Impact of Air Cleaning Devices on Novel Allergens: Silkworm Allergen (Bombyx mori – Bom m 1)
This research explores how air cleaning technologies can effectively capture and remove airborne particles of Bom m 1, a novel silkworm allergen. The results highlight the potential of these devices to play a critical role in improving indoor air quality and reducing respiratory health risks associated with emerging allergens.

These presentations reflect Airmid’s ongoing mission to deliver evidence-based insights into how indoor air quality impacts allergic diseases, aligning closely with the EAACI Congress’s broader focus on sustainability and planetary health.

See more about Oliver Dsa’s work here

Advancing the Science of Healthier Indoor Environments at EAACI 2025

Airmid Healthgroup’s participation in EAACI 2025 not only showcases their cutting-edge research but also reinforces their role as a key contributor to global conversations on allergy, asthma, and environmental health. Their expertise in microbiology, aerobiology, and bioaerosol testing continues to drive innovation in consumer product testing, certification, and public health awareness.

For more information about the EAACI Congress 2025, visit the official website:

EAACI Congress 2025.

Related Services at Airmid Healthgroup

Related Blogs from Airmid Healthgroup

Key Words

Airmid Healthgroup, EAACI Congress 2025, indoor air quality, allergen testing, asthma, environmental allergens, allergy research, asthma care, sustainable future, Glasgow, planetary health

Do you want to validate your technology?

Contact the Airmid Healthgroup team today to learn more about the independent testing process and how it can enhance your product’s credibility in the market.

Click Here

author avatar
Oliver Dsa MSc

Oliver Dsa, MSc, is a senior scientist at Airmid Healthgroup and a leading specialist in environmental virology and the transmission dynamics of airborne pathogens. With extensive experience in high-containment laboratory research and virological assay development, Oliver plays a central role in the design and execution of GLP-compliant studies that evaluate the real-world performance of antimicrobial, antiviral, and air purification technologies.

At Airmid Healthgroup, Oliver’s work supports global manufacturers, healthcare innovators, and regulatory teams by generating scientifically robust data that withstands scrutiny from FDA, EPA, ISO, and CE marking bodies. He is deeply engaged in testing solutions for infection prevention across healthcare, residential, commercial, and transport environments.

Through his contributions to Airmid’s blog, Oliver translates complex virology and bioaerosol science into actionable insights.

His writing supports product developers, indoor air quality experts, and public health professionals in navigating the fast-evolving intersection of airborne disease control, ventilation standards (including ASHRAE 241), and surface decontamination strategies.

In his blog contributions, Oliver breaks down complex scientific issues—ranging from airborne pathogens to surface decontamination and beyond—into clear, actionable insights for professionals in healthcare, building science, consumer product development, and public health.

Scroll to Top